Enorama Pharma AB (publ) (STO: ERMA)
Sweden
· Delayed Price · Currency is SEK 4.810
-0.190 (-3.80%)
Aug 30, 2024, 4:53 PM CET
Enorama Pharma AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 80.3 | 75.07 | 91.02 | 83.32 | 92.35 | 91.93 | Upgrade
|
| Revenue Growth (YoY) | 6.88% | -17.52% | 9.24% | -9.78% | 0.46% | 35.90% | Upgrade
|
| Cost of Revenue | 25.32 | 27.25 | 25.98 | 19.78 | 14.58 | 12.47 | Upgrade
|
| Gross Profit | 54.98 | 47.82 | 65.04 | 63.54 | 77.77 | 79.46 | Upgrade
|
| Selling, General & Admin | 46.29 | 41.57 | 52.41 | 47.09 | 45.92 | 43.03 | Upgrade
|
| Research & Development | 29.73 | 32.11 | 34.91 | 28.16 | 35.94 | 35.79 | Upgrade
|
| Other Operating Expenses | 0.15 | 0.61 | -2.26 | -0.21 | 1.7 | -0.02 | Upgrade
|
| Operating Expenses | 76.17 | 74.28 | 85.05 | 75.04 | 83.56 | 78.81 | Upgrade
|
| Operating Income | -21.19 | -26.46 | -20.02 | -11.5 | -5.79 | 0.65 | Upgrade
|
| Interest Expense | -1.06 | -1 | -3.41 | -0.22 | -0.1 | -0.34 | Upgrade
|
| Interest & Investment Income | 0.54 | 0.54 | - | - | 0.01 | 0.04 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.17 | 0.17 | -0.04 | 0.95 | -0.58 | -0.2 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | - | - | - | 0.05 | -0.05 | Upgrade
|
| EBT Excluding Unusual Items | -21.54 | -26.75 | -23.47 | -10.77 | -6.41 | 0.1 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -2.58 | - | - | Upgrade
|
| Pretax Income | -21.54 | -26.75 | -23.47 | -13.35 | -6.41 | 0.1 | Upgrade
|
| Income Tax Expense | -0.35 | -0.35 | -1.24 | 0.1 | 5.75 | -0.93 | Upgrade
|
| Earnings From Continuing Operations | -21.19 | -26.4 | -22.23 | -13.45 | -12.16 | 1.02 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | -0.08 | -0.43 | Upgrade
|
| Net Income | -21.19 | -26.4 | -22.23 | -13.45 | -12.24 | 0.59 | Upgrade
|
| Net Income to Common | -21.19 | -26.4 | -22.23 | -13.45 | -12.24 | 0.59 | Upgrade
|
| Shares Outstanding (Basic) | 66 | 66 | 41 | 36 | 36 | 36 | Upgrade
|
| Shares Outstanding (Diluted) | 66 | 66 | 41 | 36 | 36 | 36 | Upgrade
|
| Shares Change (YoY) | 7.95% | 58.74% | 14.02% | 0.56% | -0.18% | 0.18% | Upgrade
|
| EPS (Basic) | -0.32 | -0.40 | -0.54 | -0.37 | -0.34 | 0.02 | Upgrade
|
| EPS (Diluted) | -0.32 | -0.40 | -0.54 | -0.37 | -0.34 | 0.02 | Upgrade
|
| Free Cash Flow | -10.52 | -11.98 | 3.65 | -4.32 | 19.73 | -0.79 | Upgrade
|
| Free Cash Flow Per Share | -0.16 | -0.18 | 0.09 | -0.12 | 0.55 | -0.02 | Upgrade
|
| Gross Margin | 68.47% | 63.71% | 71.45% | 76.26% | 84.21% | 86.43% | Upgrade
|
| Operating Margin | -26.39% | -35.24% | -21.99% | -13.80% | -6.27% | 0.71% | Upgrade
|
| Profit Margin | -26.39% | -35.17% | -24.42% | -16.14% | -13.25% | 0.65% | Upgrade
|
| Free Cash Flow Margin | -13.10% | -15.95% | 4.01% | -5.18% | 21.36% | -0.86% | Upgrade
|
| EBITDA | -18.18 | -22.53 | -15.83 | -9.31 | -4.37 | 1.89 | Upgrade
|
| EBITDA Margin | -22.64% | -30.02% | -17.39% | -11.17% | -4.73% | 2.05% | Upgrade
|
| D&A For EBITDA | 3.01 | 3.92 | 4.18 | 2.19 | 1.42 | 1.24 | Upgrade
|
| EBIT | -21.19 | -26.46 | -20.02 | -11.5 | -5.79 | 0.65 | Upgrade
|
| EBIT Margin | -26.39% | -35.24% | -21.99% | -13.80% | -6.27% | 0.71% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.